ResearcherThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteActive in the last 2 years

Leah Stein

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6150-2915; OpenAlex author ID A5084341181. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2024: 1 paper

Papers 1

FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer. Co-author DOI 10.1038/s41698-024-00683-x ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sameek Roychowdhury · 1 shared paper, 2024 · strength 0.17
- Paper FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer. DOI 10.1038/s41698-024-00683-x ↗
Zachary A. Risch · 1 shared paper, 2024 · strength 0.17
- Paper FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer. DOI 10.1038/s41698-024-00683-x ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.